PAMU
HITK

Pictet Asset Management (UK)’s HI-TECH PHARMACAL INC HITK Stock Holding History

Pictet Asset Management (UK)’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-94,200
Closed -$4.08M – 905
2014
Q1 		$4.08M Buy
94,200
+6,100
+7% +$264K 0.02% 583
2013
Q4 		$3.82M Buy
88,100
+13,000
+17% +$562K 0.02% 594
2013
Q3 		$3.24M Sell
75,100
-36,200
-33% -$1.39M 0.02% 629
2013
Q2 		$3.69M Buy
+111,300
New +$3.7M 0.02% 570

Pictet Asset Management (UK)'s HITK Position: Q2 2014 in Review

Pictet Asset Management (UK) sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 94,200 shares — an estimated $4.08M sold.

Pictet Asset Management (UK) first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $4.08M in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Pictet Asset Management (UK) reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 94,200 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $4.08M.
  • Pictet Asset Management (UK) first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • Pictet Asset Management (UK)'s HI-TECH PHARMACAL INC position peaked at $4.08M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2014, filed 31 Jul 2014.